Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced the nomination of seasoned pharmaceutical...

Related Keywords

Virginia ,United States ,Pennsylvania ,Charlottesville ,University Of Rochester ,New York ,Jersey ,Rochester ,Wisconsin ,Ilanit Allen ,Citius Pharma ,Greg Salsburg ,Robertj Smith ,Leonard Mazur ,Business Advisory Board Of Ocugen Inc ,Foundation For Cell ,Operations Committee ,Securities Exchange ,Wyeth Pharmaceuticals ,Company Nasdaq ,Jersey State Biotechnology Association ,Business Administration ,Alliance For Regenerative Medicine ,Pennsylvania Biotechnology Association ,Exchange Commission ,Bamboo Therapeutics Inc ,Prnewswire Citius Pharmaceuticals Inc ,Pfizer ,Investment Advisory Committee For Venture Investors ,Citius Pharmaceuticals Inc ,Iterum Therapeutics ,Investor Relations For Citius Pharmaceuticals ,Life Sciences ,Pharmaceuticals Announces Nomination ,Pharmaceutical Executive Robert ,Annual Shareholder Meeting ,Citius Annual Shareholder Meeting ,Citius Board ,Senior Vice President ,Global Gene Therapy Business ,Global Licensing ,Iterum Therapeutics Limited ,New Jersey State Biotechnology Association ,Margolis Value Based Agreements Advisory Board ,Regenerative Medicine ,Gene Medicine ,Executive Committees ,Business Advisory Board ,Investment Advisory Committee ,Venture Investors ,Gene Therapy Scientific Advisory Board ,Focused Ultrasound Foundation ,Corporate Accounting ,Graduate School ,Citius Pharmaceuticals ,Biologics License Application ,Citius Oncology ,Securities Act ,Securities Exchange Act ,Mino Lok Phase ,Annual Report ,